S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Stock market today: Asia stocks rise follow Wall Street climbs to more all-time highs
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Stock market today: Asia stocks rise follow Wall Street climbs to more all-time highs
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Stock market today: Asia stocks rise follow Wall Street climbs to more all-time highs
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck
S&P 500   5,096.27
DOW   38,996.39
QQQ   439.00
Pure Storage, Hormel Foods rise; WW International, First Advantage fall, Thursday, 2/29/2024
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
How major US stock indexes fared Thursday, 2/29/2024
Stock market today: Asia stocks rise follow Wall Street climbs to more all-time highs
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase
Best Buy reports lower 4Q sales and profits as shoppers remain cautious
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Grads From This Midwestern School Are More Likely to Start a Billion Dollar Company Than Founders Who Went To Stanford, Harvard, or MIT: Study
It's Leap Day, and You're Probably Working — Here's How 'February 29' Affects Your Paycheck

Enliven Therapeutics (ELVN) Insider Trading & Ownership

$15.97
-1.03 (-6.06%)
(As of 02/29/2024 ET)

Enliven Therapeutics (NASDAQ:ELVN) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
45.80%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$19.45 M
Get ELVN Insider Trade Alerts

Want to know when executives and insiders are buying or selling Enliven Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ELVN Insider Buying and Selling by Quarter


Enliven Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/27/2024Benjamin HohlCFOSell3,250$16.97$55,152.50  
2/15/2024Richard A HeymanDirectorSell1,270$17.42$22,123.40  
2/6/2024Anish PatelCOOSell4,875$15.11$73,661.25  
1/31/20245Am Partners Vi, LlcMajor ShareholderSell500,000$15.00$7,500,000.00  
1/30/2024Richard A HeymanDirectorSell1,270$16.41$20,840.70  
1/29/2024Benjamin HohlCFOSell3,250$15.81$51,382.50  
1/29/2024Joseph P. LyssikatosinsiderSell12,000$15.85$190,200.00  
1/25/2024Samuel KintzCEOSell12,000$15.69$188,280.00  
1/22/2024Anish PatelCOOSell4,875$15.13$73,758.75  
1/2/2024Anish PatelCOOSell11,000$15.00$165,000.00  
1/2/2024Benjamin HohlCFOSell9,383$15.01$140,838.83  
12/26/2023Anish PatelCOOSell102$15.01$1,531.02  
12/26/2023Benjamin HohlCFOSell100$15.00$1,500.00  
12/26/2023Samuel KintzCEOSell12,000$14.64$175,680.00  
12/22/2023Anish PatelCOOSell983$15.03$14,774.49  
12/22/2023Benjamin HohlCFOSell1,030$15.07$15,522.10  
12/22/2023Samuel KintzCEOSell8,175$13.05$106,683.75  
12/21/2023Joseph P. LyssikatosinsiderSell20$13.00$260.00  
12/21/2023Richard A HeymanDirectorSell7$13.00$91.00  
12/20/2023Samuel KintzCEOSell7,779$13.01$101,204.79  
12/19/2023Joseph P. LyssikatosinsiderSell200$13.00$2,600.00  
12/19/2023Richard A HeymanDirectorSell255$13.00$3,315.00  
11/3/2023Joseph P. LyssikatosinsiderSell8,546$13.08$111,781.68  
11/3/2023Samuel KintzCEOSell8,026$13.08$104,980.08  
9/29/2023Joseph P. LyssikatosinsiderSell12,000$13.62$163,440.00  
9/26/20235Am Partners Vi, LlcMajor ShareholderSell197,500$15.00$2,962,500.00  
9/25/2023Samuel KintzCEOSell12,000$13.81$165,720.00  
8/24/20235Am Partners Vi, LlcMajor ShareholderSell440,000$16.00$7,040,000.00  
(Data available from 1/1/2013 forward)












ELVN Insider Trading Activity - Frequently Asked Questions

Who is on Enliven Therapeutics's Insider Roster?

The list of insiders at Enliven Therapeutics includes 5Am Partners Vi, Llc, Anish Patel, Benjamin Hohl, Joseph P. Lyssikatos, Richard A Heyman, and Samuel Kintz. Learn more on insiders at ELVN.

What percentage of Enliven Therapeutics stock is owned by insiders?

45.80% of Enliven Therapeutics stock is owned by insiders. Learn more on ELVN's insider holdings.

Which Enliven Therapeutics insiders have been selling company stock?

The following insiders have sold ELVN shares in the last 24 months: 5Am Partners Vi, Llc ($17,502,500.00), Anish Patel ($328,725.51), Benjamin Hohl ($264,395.93), Joseph P. Lyssikatos ($468,281.68), Richard A Heyman ($46,370.10), and Samuel Kintz ($842,548.62).

How much insider selling is happening at Enliven Therapeutics?

Insiders have sold a total of 1,271,896 Enliven Therapeutics shares in the last 24 months for a total of $19,452,821.84 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:ELVN) was last updated on 3/1/2024 by MarketBeat.com Staff